Abstract
The European Association of Urology guidelines on prostate cancer state that cryotherapy is a true therapeutic alternative for patients with clinically localized prostate cancer. The aim of this paper is to establish a uniform practice for performing prostate cryoablation. A collaboration has been set up among five European centres with experience in almost 1000 prostate cancer patients on the use of cryotherapy. The present recommendations were developed through sharing of experience and thorough discussions within the group. This first paper from the group establishes the technical recommendations for use of prostate cryotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van Poppel H et al. EAU guidelines on prostate cancer. Eur Urol 2005; 48: 546.
American Urological Association. Best policy statement on the treatment of cryosurgery for the treatment of localized prostate cancer. AUA Annual Meeting, Maryland, 17–22 May 2008.
National Institute of Clinical Excellence. Cryotherapy as a primary treatment for prostate cancer. 2005.
National Institute of Clinical Excellence. Cryotherapy for recurrent prostate cancer. 2005. www.nice.org.uk.
Baust JG, Gage AA . The molecular basis of cryosurgery. BJU Int 2005; 95: 1187.
Clarke DM, Baust JM, Van Buskirk RG, Baust JG . Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement. Cryobiology 2004; 49: 45.
Tatsutani K, Rubinsky B, Onik G, Dahiya R . Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology 1996; 48: 441.
Soanes WA, Gonder MJ . Use of cryosurgery in prostatic cancer. J Urol 1968; 99: 793.
EAU guidelines on prostate cancer. http://www.uroweb.org/files/uploaded_files/guidelines/07%20Prostate%20Cancer.pdf
Lane BR, Stein DE, Remzi FH, Strong SA, Fazio VW, Angermeier KW . Management of radiotherapy induced rectourethral fistula. J Urol 2006; 175: 1382.
Moreira Jr SG, Seigne JD, Ordorica RC, Marcet J, Pow-Sang JM, Lockhart JL . Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma. BJU Int 2004; 93: 31.
Cytron S, Paz A, Kravchick S, Shumalinski D, Moore J . Active rectal wall protection using direct transperineal cryo-needles for histologically proven prostate adenocarcinomas. Eur Urol 2003; 44: 315.
Izawa JI, Perrotte P, Greene GF, Scott S, Levy L, McGuire E et al. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. J Urol 2001; 165: 86.
Chin JL, Touma N, Pautler SE, Guram KS, Bella AJ, Downey DB et al. Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure. J Urol 2003; 170 (4 Pt 1): 1199.
Touma NJ, Izawa JI, Chin JL . Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 2005; 173: 373.
Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT . Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 1995; 153: 104.
Amling CL, Lerner SE, Martin SK, Slezak JM, Blute ML, Zincke H . Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 1999; 161: 857.
Ahlering TE, Lieskovsky G, Skinner DG . Salvage surgery plus androgen deprivation for radioresistant prostatic adenocarcinoma. J Urol 1992; 147 (3 Pt 2): 900.
Garzotto M, Wajsman Z . Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: results at 5-year followup. J Urol 1998; 159: 950.
Izawa JI, Madsen LT, Scott SM, Tran JP, McGuire EJ, Von Eschenbach AC et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol 2002; 20: 2664.
Katz AE, Ghafar MA . Selection of salvage cryotherapy patients. Rev Urol 2002; 4 (Suppl 2): S18.
De La Taille A, Benson MC, Bagiella E, Burchardt M, Shabsigh A, Olsson CA et al. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int 2000; 85: 281.
Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M . Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002; 60 (2 Suppl 1): 3.
Consensus statement. Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37: 1035.
Shelley M, Wilt TJ, Coles B, Mason MD . Cryotherpay for localised prostate cancer. Cochrane database Syst Rev 2007, July 18(3): CD005010.
Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE . Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol 2008; 180: 554.
Acknowledgements
This manuscript was supported by an unrestricted educational grant from Galil.
Author information
Authors and Affiliations
Corresponding author
Additional information
Key messages: Cryotherapy is a recommended primary treatment for localized prostate cancer and as salvage therapy in prostate cancer patients failing radiotherapy.
Rights and permissions
About this article
Cite this article
Cytron, S., Greene, D., Witzsch, U. et al. Cryoablation of the prostate: technical recommendations. Prostate Cancer Prostatic Dis 12, 339–346 (2009). https://doi.org/10.1038/pcan.2009.26
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/pcan.2009.26
Keywords
This article is cited by
-
Comparison of ablation defect on MR imaging with computer simulation estimated treatment zone following irreversible electroporation of patient prostate
SpringerPlus (2016)
-
Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer
British Journal of Cancer (2014)